AuroLab engineers its first high-quality intraocular lenses to address the cost barrier. This foundational step enabled millions worldwide to access safe cataract care.
Launch of pharmaceutical division with 5 essential drugs. Now offers eye drops, OVDs, dyes, and surgical adjuncts.
AuroLab expands to new markets globally, exporting high-quality ophthalmic products worldwide.
Established an in-house R&D division to focus on innovation and clinical research.
New Division for Comprehensive Care Solutions.
Received USFDA for Nylon Sutures.First Participation in AAO Conference.
Established Surgical Blade & Equipment Divisions.
Inaugurated New Facility—Enhancing Precision and Capacity.
Advancing Vision Care with Cutting-Edge Innovation.
1 Million Aurovue IOLs Implanted Worldwide.
1 Million Aurovue IOLs Implanted Worldwide.
Phoenix Multispot Laser, Suture 25-Year Milestone, State-of-the-Art Warehouse Inaugurated (1 Lakh Sq Ft).
Redefining our identity and communication to reflect our legacy and vision care leadership.
Instituted a 50,000 Sq Ft, FDA compliant Eye Drop facility.